Alligator Bioscience Logo

Alligator Bioscience

Develops immuno-oncology antibody drugs to activate the immune system against hard-to-treat cancers.

ATORX | ST

Overview

Corporate Details

ISIN(s):
SE0000767188 (+8 more)
LEI:
549300E15VI0MB7LXV19
Country:
Sweden
Address:
C/O Medicon Village, 223 81 Lund
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alligator Bioscience is a clinical-stage biotechnology company that develops tumor-directed immuno-oncology antibody drugs. The company specializes in creating antibody-based pharmaceuticals designed to activate the patient's immune system for cancer treatment. Its proprietary technology platform and drug discovery engine support a pipeline of immunotherapies, with a significant focus on the CD40 pathway. A key product in its pipeline is mitazalimab, a CD40 agonist being developed for hard-to-treat cancers, including pancreatic cancer.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-23 08:00
Quarterly Report
Swedish 1.2 MB
2025-10-23 08:00
Quarterly Report
English 1.2 MB
2025-10-22 23:55
Pre-Annual General Meeting Information
Kallelse till extra bolagsstämma i Alligator Bioscience AB
Swedish 93.3 KB
2025-10-22 23:55
Pre-Annual General Meeting Information
Notice of extraordinary general meeting in Alligator Bioscience AB
English 98.5 KB
2025-10-22 23:05
Share Issue/Capital Change
Alligator Bioscience carries out a rights issue of units of approximately SEK 1…
English 114.4 KB
2025-10-22 23:05
Share Issue/Capital Change
Alligator Bioscience genomför en företrädesemission av units om cirka 120 MSEK …
Swedish 113.8 KB
2025-10-17 09:50
Major Shareholding Notification
Swedish 10.5 KB
2025-10-14 11:07
Major Shareholding Notification
Swedish 10.9 KB
2025-10-13 11:43
Major Shareholding Notification
Swedish 9.6 KB
2025-10-09 11:42
Major Shareholding Notification
Swedish 10.9 KB
2025-10-06 10:45
Major Shareholding Notification
Swedish 10.9 KB
2025-10-03 10:45
Major Shareholding Notification
Swedish 10.9 KB
2025-10-01 09:40
Major Shareholding Notification
Swedish 10.1 KB
2025-09-30 15:00
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Alligator Bioscience AB
English 54.8 KB
2025-09-30 15:00
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Alligator Bioscience AB
Swedish 55.3 KB

Automate Your Workflow. Get a real-time feed of all Alligator Bioscience filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alligator Bioscience

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alligator Bioscience via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-28 Peter Ostler Other Sell 1,658,134 179,045.31 SEK
2024-04-11 Staffan Encrantz Other Sell 44,108,581 47,196,181.67 SEK
2022-10-27 Sören Bregenholt Frederiksen Other Buy 52,000 72,748.00 SEK
2022-10-25 Marie Svensson Other Buy 12,000 16,632.00 SEK
2022-08-19 Sören Bregenholt Frederiksen Other Buy 13,906 25,726.10 SEK
2022-08-18 Sören Bregenholt Frederiksen Other Buy 31,094 56,911.35 SEK
2022-05-31 Peter Ostler Other Buy 100,000 151,500.00 SEK
2022-05-04 Sören Bregenholt Frederiksen Other Buy 30,000 50,895.00 SEK
2022-05-02 Sören Bregenholt Frederiksen Other Buy 30,000 50,811.00 SEK
2022-04-30 Sören Bregenholt Frederiksen Other Buy 30,000 51,171.00 SEK

Peer Companies

Company Country Ticker View
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780
Aptahem AB Logo
Develops RNA aptamers to treat acute, life-threatening conditions like sepsis.
Sweden APTA

Talk to a Data Expert

Have a question? We'll get back to you promptly.